Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
-
Shares outstanding
-
125,610,040
-
Total 13F shares
-
77,790,536
-
Share change
-
+4,399,526
-
Total reported value
-
$974,764,447
-
Put/Call ratio
-
83%
-
Price per share
-
$12.43
-
Number of holders
-
112
-
Value change
-
+$68,457,241
-
Number of buys
-
61
-
Number of sells
-
37
Institutional Holders of Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) as of Q4 2024
As of 31 Dec 2024,
Indivior Pharmaceuticals, Inc. - Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,790,536 shares.
The largest 10 holders included
Two Seas Capital LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), OAKTREE CAPITAL MANAGEMENT LP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, Madison Avenue Partners, LP, MORGAN STANLEY, Jefferies Financial Group Inc., SCOPIA CAPITAL MANAGEMENT LP, and Newtyn Management, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.